Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

Single usage, open label study in up to 40 adult healthy males. Eligible subjects will receive a single usage of the investigational or commercial device. Retention of the radiolabeled device will be monitored using gamma scintigraphy.

Key facts

Study ID

NCT00780286

Run by

Procter and Gamble

People needed

32

Starts

2008-10-01

Expected to finish

2008-10-01

Last updated by the study team

2019-04-02

Who can join

Age: 18 and older, up to 40. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Refrain from nasal, throat, or lung inhalants and exercise for 24 hour prior to the test
• Are able to tolerate the procedure and
• Be generally healthy

You may not qualify if…

• Have history of allergy or hypersensitivity to the study ingredients
• Major diseases
• Taking medication regularly
• Radiation exposure recently

Where it is running

• Walter J Doll, PhD, RPh — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.